HSV

Severe Oral Mucositis: A Rare Adverse Event of Pembrolizumab
Oral Mucositis
by NEXT STEPS IN DERM TEAM on
Treatment of malignancy with anti-programmed cell death 1 (PD-1) immune checkpoint inhibitors can cause mucocutaneous side effects resulting from T cell activation. Due to their recent development, the full side effect profile remains to be fully elucidated, however dermatologic adverse events are most common. The main oral toxicities of these immune checkpoint inhibitors include: xerostomia, dysg …